Barbara Osborne to Clinical Trials as Topic
This is a "connection" page, showing publications Barbara Osborne has written about Clinical Trials as Topic.
Connection Strength
0.050
-
Ran Y, Hossain F, Pannuti A, Lessard CB, Ladd GZ, Jung JI, Minter LM, Osborne BA, Miele L, Golde TE. ?-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. EMBO Mol Med. 2017 07; 9(7):950-966.
Score: 0.028
-
Golde TE, Koo EH, Felsenstein KM, Osborne BA, Miele L. ?-Secretase inhibitors and modulators. Biochim Biophys Acta. 2013 Dec; 1828(12):2898-907.
Score: 0.021